Insulin patch for type 2 diabetes
Part of Hormones & metabolism clinical trials.
This trial tests a new way to give insulin using a patch on your skin instead of a needle. It could make managing your blood sugar easier and help you avoid daily injections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 25 and 75 years old.
- You have type 2 diabetes and currently take insulin by injection (not using an insulin pump).
- Your blood sugar levels are fairly stable, usually between 85 and 200 mg/dL.
- You have had no more than 1 serious low blood sugar episode in the last 9 months.
- You are willing to wear a continuous glucose monitor and share the data with the study team.
- Your current insulin dose per injection is between 10 and 200 units.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This trial tests a special patch that helps keep continuous glucose monitor (CGM) sensors in place longer. It is for people with diabetes who have trouble keeping their sensor on and have high blood sugar levels.
This trial tests a 'closed-loop' system that automatically adjusts insulin delivery for people with type 2 diabetes. If you already use insulin and certain diabetes medications, this study could help see if a smart insulin pump improves blood sugar control.
This trial tests a new implantable insulin pump for adults with type 1 diabetes that is difficult to manage with shots or external pumps. The pump is placed under the skin and delivers insulin automatically, aiming to reduce dangerous highs and lows in blood sugar.
This study compares a continuous “under the skin” diabetes medicine (called beinaglutide) with an insulin pump (CSII) in people who were recently diagnosed with type 2 diabetes. It aims to see which approach works better and is safer for controlling blood sugar.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
Hear when a new Glucose, High Blood trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.